We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OMU:LSEOld Mutual Ltd. Analysis

Data as of 2026-06-13 - not real-time

£61.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Old Mutual Limited trades at £0.616 per share, well below its 20‑day (£59.23), 50‑day (£60.42) and 200‑day (£62.78) simple moving averages, indicating a bearish price bias. The RSI sits at 56.5, suggesting neutral momentum, while the MACD histogram is positive (0.37) despite a bearish overall trend. Fundamentally, the stock appears significantly undervalued with a trailing P/E of 6.84 versus an industry average of 16.83, a price‑to‑book below 1, and a dividend yield of 6.59% supported by a payout ratio under 50% and strong free cash flow. Revenue growth of 20% and solid gross (31%) and operating (20%) margins further bolster the case, even though the balance sheet shows a high debt‑to‑equity ratio offset by a massive cash pile. Volatility is elevated at over 40% (30‑day) and beta is low (0.34), while market sentiment is in an Extreme Greed phase (Fear‑Greed Index 89.86).
Given the stable volume, clear support at £56.40 and resistance near £64.20, combined with the company’s strong dividend profile and undervaluation relative to peers, the stock presents a compelling value play. However, the bearish technical backdrop and regulatory compliance requirements in South Africa introduce medium‑level risks that investors should monitor.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major SMAs indicating bearish bias
  • Positive MACD histogram suggests potential short‑term bounce
  • High volatility and proximity to support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry P/E and price‑to‑book
  • Strong dividend yield with sustainable payout
  • Revenue growth and solid operating margins

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust cash position offsetting high debt
  • Consistent dividend income and low beta
  • Fundamental value thesis supported by low valuation multiples

Key Metrics & Analysis

Financial Health

Revenue Growth19.90%
Profit Margin7.13%
P/E Ratio6.8
ROE14.77%
ROA1.06%
Debt/Equity93.42
P/B Ratio0.9
Op. Cash Flow£-2471000064
Free Cash Flow£76.8B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI56.5
Support£56.40
Resistance£64.20
MA 20£59.23
MA 50£60.42
MA 200£62.78
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value£59,080.69
Target Price£62.00
Upside/Downside0.65%
GradeUndervalued
TypeValue
Dividend Yield6.59%

Risk Assessment

Beta0.34
Volatility40.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.